Tissue Engineered Skin Substitute Market Report 2025

This tissue engineered skin substitute market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The tissue engineered skin substitute market size has grown strongly in recent years. It will grow from $1.86 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing funding from government agencies, increasing focus on personalized medicine, increasing funding from government agencies.

The tissue engineered skin substitute market size is expected to see strong growth in the next few years. It will grow to $2.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals and standards, greater focus on sustainability, growth in specialized clinics, and expansion of educational programs and training. Major trends in the forecast period include advancements in biomaterials, enhanced cellular therapies, post-market surveillance and data collection, advancements in personalized medicine and shifts in consumer preferences.

The rising incidence of accidents is projected to drive the growth of the tissue-engineered skin substitute market in the future. This increase in accidents can be attributed to factors such as higher traffic volumes, distracted driving, insufficient road maintenance, and the growing use of mobile devices while driving. Tissue-engineered skin substitutes offer a functional and biocompatible alternative for damaged skin, facilitating faster healing and minimizing complications like infections and scarring. For example, in June 2024, the Insurance Institute for Highway Safety and Highway Loss Data Institute, a U.S.-based nonprofit organization, reported that the number of individuals aged 70 and older who died in motor vehicle crashes rose from 5,245 in 2021 to 5,626 in 2022. Therefore, the increasing incidence of accidents is driving the growth of the tissue-engineered skin substitute market.

Key players in the tissue-engineered skin substitute market are concentrating on the development of advanced technologies like bioprinting to improve the precision and efficiency of creating complex skin layers, thereby enhancing the integration of skin substitutes with natural skin. Bioprinting technology allows for the accurate fabrication of intricate skin structures by layering cells, biomaterials, and growth factors, which fosters better tissue regeneration and integration with existing skin. For example, in November 2022, Avay Biosciences Private Limited, an India-based manufacturer of 3D bioprinters for tissues and organs, introduced the indigenous Mito Plus 3D printer, capable of printing human tissues. This printer uses specialized materials known as bioinks to replicate living tissues and is equipped with features like UV curing options, HEPA filters, and precise temperature control, making it suitable for diverse applications, including drug discovery and testing in the pharmaceutical and cosmetology sectors.

In March 2023, Aziyo Biologics Inc., a US-based regenerative medicine company, entered into a partnership with Sientra Inc. This collaboration is focused on expanding the distribution of Aziyo's SimpliDerm product line, a tissue-engineered skin substitute. Under this agreement, Sientra will have non-exclusive rights to market, sell, and distribute SimpliDerm in the US for specific applications in reconstruction surgery. Sientra Inc. specializes in aesthetic medicine and plastic surgery implants.

Major companies operating in the tissue engineered skin substitute market are Stryker Corporation, DePuy Synthes, Smith & Nephew Plc, ConvaTec Group PLC, Mallinckrodt Pharmaceuticals plc, Integra LifeSciences Holdings Corporation, Gunze Limited, Organogenesis Inc., LifeNet Health Inc., MiMedx Group Inc., Vericel Corporation, AlloSource Inc., Sientra Inc., PolyNovo Limited, Avita Medical Limited, Tissue Regenix Group, Amarantus Bioscience Holdings Inc., PolarityTE, Promethean LifeSciences Inc., Regenicin Inc.

North America was the largest region in the tissue engineered skin substitute market in 2023. The regions covered in the tissue engineered skin substitute market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue engineered skin substitute market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A tissue-engineered skin substitute is a lab-created material designed to replicate the properties of natural skin. It combines cells, biomaterials, and growth factors to create a functional, skin-like layer that aids in healing and restoring skin integrity for patients with severe wounds or burns.

The main types of tissue-engineered skin substitutes include acellular skin substitutes, biologic skin substitutes, cellular skin substitutes, and synthetic skin substitutes. Acellular skin substitutes are constructed from materials with all cells removed, leaving a scaffold that supports the body's own cells in growing and repairing the skin. These substitutes can be made from both synthetic and natural materials using various technologies such as laser-assisted bio-printing, 3D printing, and robotic technology. They are used for different applications, including chronic and acute wounds. End users of these products include hospitals, specialty clinics, ambulatory surgical centers, and research laboratories.

The tissue-engineered skin substitutes market research report is one of a series of new reports that provides tissue-engineered skin substitutes market statistics, including tissue-engineered skin substitutes industry global market size, regional shares, competitors with a tissue-engineered skin substitutes market share, detailed tissue-engineered skin substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the tissue-engineered skin substitutes industry. This tissue-engineered skin substitutes market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue-engineered skin substitute market consists of sales of products including apligraf, dermagraft, epicel, matristem, and stratagraft. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.